Cargando…
Rethink the patentability of human embryonic stem cell research findings: Relaxation based on benefit weighing
Attitudes toward the patentability of the human embryonic stem cell (hESC) research findings are undergoing dynamic adjustment based on benefit weighing. In the early stage, ethical concerns prevailed: both the United States and China placed restrictions to some extent. As the science and technologi...
Autores principales: | Chen, Jiajv, Li, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365090/ https://www.ncbi.nlm.nih.gov/pubmed/34380021 http://dx.doi.org/10.1016/j.stemcr.2021.07.005 |
Ejemplares similares
-
How to promote the accessibility of technology in the era of hESC patents—A comparative analysis of the systems of the US and China
por: Zhang, Wei, et al.
Publicado: (2023) -
From strict moral standards to ethical neutrality: a policy-guided shift in the patentability of human embryonic stem cells in China
por: Xie, Xuekai, et al.
Publicado: (2020) -
Rethinking Benefits in Health Research, Reflections of an Ethics
Committee
por: Mondragón Barrios, Liliana, et al.
Publicado: (2022) -
Rethinking Opsins
por: Feuda, Roberto, et al.
Publicado: (2022) -
Weighing in on monkeypox against the criteria of public health emergency
por: Lamptey, Emmanuel
Publicado: (2023)